USA Pertussis Vaccine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Pertussis vaccine is an acute respiratory infectious disease caused by Pertussis bacilli, which is mainly transmitted by carriers or early patients to infants and other susceptible people through droplets, and the infection course can be as long as 2 to 3 months. The pertussis vaccine is generally used together with vaccines for other diseases to prevent three diseases of pertussis, diphtheria, and tetanus at the same time.

    Infants and young children suffering from Pertussis may cause serious consequences, prone to suffocation, pneumonia, and other complications. In recent years, the incidence of Pertussis has increased globally. In order to strengthen the protection of newborns, governments of all countries have promoted the vaccination of Pertussis vaccines, such as increasing medical insurance and reimbursement, which has promoted the development of the Pertussis vaccines market. The strengthening of people's health awareness has also promoted the development of the Pertussis vaccine market to a certain extent.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Pertussis Vaccine market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Pertussis Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Pertussis Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Astellas Pharma

    • Changchun Changsheng

    • Mitsubishi Tanabe Pharma

    • Biological Products

    • Biological Products

    • Life Sciences

    • GSK

    • Wuhan Institute of

    • Minhai Biotechnology

    • Chengdu Institute of

    • GSK

    • Sanofi Pasteur

    • GSK

    By Type:

    • Whole-cell vaccines

    • Acellular vaccines

    • Others

    By End-User:

    • Children

    • Adults

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pertussis Vaccine Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Pertussis Vaccine Market Size and Growth Rate of Whole-cell vaccines from 2016 to 2027

      • 1.3.2 USA Pertussis Vaccine Market Size and Growth Rate of Acellular vaccines from 2016 to 2027

      • 1.3.3 USA Pertussis Vaccine Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Pertussis Vaccine Market Size and Growth Rate of Children from 2016 to 2027

      • 1.4.2 USA Pertussis Vaccine Market Size and Growth Rate of Adults from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Pertussis Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Pertussis Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Pertussis Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Pertussis Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Pertussis Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pertussis Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Whole-cell vaccines

      • 3.4.2 Market Size and Growth Rate of Acellular vaccines

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Pertussis Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pertussis Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pertussis Vaccine in Children

      • 4.4.2 Market Size and Growth Rate of Pertussis Vaccine in Adults

    5 Market Analysis by Regions

    • 5.1 USA Pertussis Vaccine Production Analysis by Regions

    • 5.2 USA Pertussis Vaccine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Pertussis Vaccine Landscape Analysis

    • 6.1 West USA Pertussis Vaccine Landscape Analysis by Major Types

    • 6.2 West USA Pertussis Vaccine Landscape Analysis by Major End-Users

    7 South USA Pertussis Vaccine Landscape Analysis

    • 7.1 South USA Pertussis Vaccine Landscape Analysis by Major Types

    • 7.2 South USA Pertussis Vaccine Landscape Analysis by Major End-Users

    8 Middle West USA Pertussis Vaccine Landscape Analysis

    • 8.1 Middle West USA Pertussis Vaccine Landscape Analysis by Major Types

    • 8.2 Middle West USA Pertussis Vaccine Landscape Analysis by Major End-Users

    9 Northeast USA Pertussis Vaccine Landscape Analysis

    • 9.1 Northeast USA Pertussis Vaccine Landscape Analysis by Major Types

    • 9.2 Northeast USA Pertussis Vaccine Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Astellas Pharma

        • 10.1.1 Astellas Pharma Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Changchun Changsheng

        • 10.2.1 Changchun Changsheng Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Mitsubishi Tanabe Pharma

        • 10.3.1 Mitsubishi Tanabe Pharma Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Biological Products

        • 10.4.1 Biological Products Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Biological Products

        • 10.5.1 Biological Products Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Life Sciences

        • 10.6.1 Life Sciences Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 GSK

        • 10.7.1 GSK Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Wuhan Institute of

        • 10.8.1 Wuhan Institute of Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Minhai Biotechnology

        • 10.9.1 Minhai Biotechnology Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Chengdu Institute of

        • 10.10.1 Chengdu Institute of Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 GSK

        • 10.11.1 GSK Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Sanofi Pasteur

        • 10.12.1 Sanofi Pasteur Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 GSK

        • 10.13.1 GSK Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Pertussis Vaccine Market Size and Growth Rate of Whole-cell vaccines from 2016 to 2027

    • Figure USA Pertussis Vaccine Market Size and Growth Rate of Acellular vaccines from 2016 to 2027

    • Figure USA Pertussis Vaccine Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Pertussis Vaccine Market Size and Growth Rate of Children from 2016 to 2027

    • Figure USA Pertussis Vaccine Market Size and Growth Rate of Adults from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Pertussis Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Pertussis Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Pertussis Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Pertussis Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Pertussis Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Pertussis Vaccine

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pertussis Vaccine by Different Types from 2016 to 2027

    • Table Consumption Share of Pertussis Vaccine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Whole-cell vaccines

    • Figure Market Size and Growth Rate of Acellular vaccines

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Pertussis Vaccine by Different End-Users from 2016 to 2027

    • Table Consumption Share of Pertussis Vaccine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Children

    • Figure Market Size and Growth Rate of Adults

    • Table USA Pertussis Vaccine Production by Regions

    • Table USA Pertussis Vaccine Production Share by Regions

    • Figure USA Pertussis Vaccine Production Share by Regions in 2016

    • Figure USA Pertussis Vaccine Production Share by Regions in 2021

    • Figure USA Pertussis Vaccine Production Share by Regions in 2027

    • Table USA Pertussis Vaccine Consumption by Regions

    • Table USA Pertussis Vaccine Consumption Share by Regions

    • Figure USA Pertussis Vaccine Consumption Share by Regions in 2016

    • Figure USA Pertussis Vaccine Consumption Share by Regions in 2021

    • Figure USA Pertussis Vaccine Consumption Share by Regions in 2027

    • Table West USA Pertussis Vaccine Consumption by Types from 2016 to 2027

    • Table West USA Pertussis Vaccine Consumption Share by Types from 2016 to 2027

    • Figure West USA Pertussis Vaccine Consumption Share by Types in 2016

    • Figure West USA Pertussis Vaccine Consumption Share by Types in 2021

    • Figure West USA Pertussis Vaccine Consumption Share by Types in 2027

    • Table West USA Pertussis Vaccine Consumption by End-Users from 2016 to 2027

    • Table West USA Pertussis Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Pertussis Vaccine Consumption Share by End-Users in 2016

    • Figure West USA Pertussis Vaccine Consumption Share by End-Users in 2021

    • Figure West USA Pertussis Vaccine Consumption Share by End-Users in 2027

    • Table South USA Pertussis Vaccine Consumption by Types from 2016 to 2027

    • Table South USA Pertussis Vaccine Consumption Share by Types from 2016 to 2027

    • Figure South USA Pertussis Vaccine Consumption Share by Types in 2016

    • Figure South USA Pertussis Vaccine Consumption Share by Types in 2021

    • Figure South USA Pertussis Vaccine Consumption Share by Types in 2027

    • Table South USA Pertussis Vaccine Consumption by End-Users from 2016 to 2027

    • Table South USA Pertussis Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Pertussis Vaccine Consumption Share by End-Users in 2016

    • Figure South USA Pertussis Vaccine Consumption Share by End-Users in 2021

    • Figure South USA Pertussis Vaccine Consumption Share by End-Users in 2027

    • Table Middle West USA Pertussis Vaccine Consumption by Types from 2016 to 2027

    • Table Middle West USA Pertussis Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Pertussis Vaccine Consumption Share by Types in 2016

    • Figure Middle West USA Pertussis Vaccine Consumption Share by Types in 2021

    • Figure Middle West USA Pertussis Vaccine Consumption Share by Types in 2027

    • Table Middle West USA Pertussis Vaccine Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Pertussis Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Pertussis Vaccine Consumption Share by End-Users in 2016

    • Figure Middle West USA Pertussis Vaccine Consumption Share by End-Users in 2021

    • Figure Middle West USA Pertussis Vaccine Consumption Share by End-Users in 2027

    • Table Northeast USA Pertussis Vaccine Consumption by Types from 2016 to 2027

    • Table Northeast USA Pertussis Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Pertussis Vaccine Consumption Share by Types in 2016

    • Figure Northeast USA Pertussis Vaccine Consumption Share by Types in 2021

    • Figure Northeast USA Pertussis Vaccine Consumption Share by Types in 2027

    • Table Northeast USA Pertussis Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Pertussis Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Pertussis Vaccine Consumption Share by End-Users in 2016

    • Figure Northeast USA Pertussis Vaccine Consumption Share by End-Users in 2021

    • Figure Northeast USA Pertussis Vaccine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma

    • Table Company Profile and Development Status of Changchun Changsheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changchun Changsheng

    • Figure Sales and Growth Rate Analysis of Changchun Changsheng

    • Figure Revenue and Market Share Analysis of Changchun Changsheng

    • Table Product and Service Introduction of Changchun Changsheng

    • Table Company Profile and Development Status of Mitsubishi Tanabe Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe Pharma

    • Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe Pharma

    • Figure Revenue and Market Share Analysis of Mitsubishi Tanabe Pharma

    • Table Product and Service Introduction of Mitsubishi Tanabe Pharma

    • Table Company Profile and Development Status of Biological Products

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biological Products

    • Figure Sales and Growth Rate Analysis of Biological Products

    • Figure Revenue and Market Share Analysis of Biological Products

    • Table Product and Service Introduction of Biological Products

    • Table Company Profile and Development Status of Biological Products

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biological Products

    • Figure Sales and Growth Rate Analysis of Biological Products

    • Figure Revenue and Market Share Analysis of Biological Products

    • Table Product and Service Introduction of Biological Products

    • Table Company Profile and Development Status of Life Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Life Sciences

    • Figure Sales and Growth Rate Analysis of Life Sciences

    • Figure Revenue and Market Share Analysis of Life Sciences

    • Table Product and Service Introduction of Life Sciences

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Wuhan Institute of

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wuhan Institute of

    • Figure Sales and Growth Rate Analysis of Wuhan Institute of

    • Figure Revenue and Market Share Analysis of Wuhan Institute of

    • Table Product and Service Introduction of Wuhan Institute of

    • Table Company Profile and Development Status of Minhai Biotechnology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Minhai Biotechnology

    • Figure Sales and Growth Rate Analysis of Minhai Biotechnology

    • Figure Revenue and Market Share Analysis of Minhai Biotechnology

    • Table Product and Service Introduction of Minhai Biotechnology

    • Table Company Profile and Development Status of Chengdu Institute of

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chengdu Institute of

    • Figure Sales and Growth Rate Analysis of Chengdu Institute of

    • Figure Revenue and Market Share Analysis of Chengdu Institute of

    • Table Product and Service Introduction of Chengdu Institute of

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Sanofi Pasteur

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur

    • Figure Sales and Growth Rate Analysis of Sanofi Pasteur

    • Figure Revenue and Market Share Analysis of Sanofi Pasteur

    • Table Product and Service Introduction of Sanofi Pasteur

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.